Systemic enzymes — taken between meals to be ABSORBED rather than digest food — are a distinct category from digestive enzymes. Wobenzym (bromelain + trypsin + rutosid) is the most studied product, with a 2004 non-inferiority trial showing it was EQUAL to diclofenac (NSAID) for knee osteoarthritis pain relief. Our research shows the mechanism involves clearing immune complexes (CIC — circulating immune complexes) and reducing fibrin deposits at inflammation sites. The concept: proteolytic enzymes like bromelain and trypsin enter the bloodstream via intestinal absorption (5-10% bioavailability) and break down inflammatory proteins systemically. This is well-established in German medicine but skeptically viewed in the US.
Systemic proteolytic enzymes (bromelain, trypsin, papain, serrapeptase): (1) Absorbed from intestine into bloodstream (5-10% of oral dose — enteric coating required to survive stomach acid); (2) In the bloodstream, they bind to alpha-2-macroglobulin (the body's protease carrier protein) — this complex retains enzymatic activity while being protected from immune clearance; (3) The enzyme-A2M complex breaks down fibrin deposits at inflammation sites (fibrin forms the structural "scaffold" of inflammatory swelling); (4) Degrades circulating immune complexes (CIC) — CIC are antibody-antigen clusters that deposit in tissues and activate complement, driving chronic inflammation; (5) Modulates cytokine production — reduces TNF-α and IL-1β while increasing IL-10 (anti-inflammatory shift).
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.